Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Darien BJ et al. | Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model. | 1998 | Shock | pmid:9565256 |
Muscará MN et al. | Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. | 1998 | Life Sci. | pmid:9566780 |
Davì G et al. | Increased thromboxane metabolites excretion in liver cirrhosis. | 1998 | Thromb. Haemost. | pmid:9569186 |
Kosugi T et al. | Glomerular thromboxane contributes to pressor response in deoxycorticosterone acetate-salt hypertension. | 1998 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9578151 |
Failli P et al. | Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. | 1998 | Br. J. Pharmacol. | pmid:9579743 |
Fuse S et al. | Plasma thromboxane B2 concentration in patients with ventricular septal defect and pulmonary hypertension. | 1998 | Jpn. Circ. J. | pmid:9583446 |
Stamler A et al. | Low-dose dopexamine's effect on lung and gut function after CPB in a sheep model. | 1998 | J. Surg. Res. | pmid:9587356 |
Inoue H et al. | Changes in endothelin-1, 6-keto-PG-F1 alpha, and TX-B2 in random pattern flaps. | 1998 | J. Cardiovasc. Pharmacol. | pmid:9595517 |
Kalgutkar AS et al. | Aspirin-like molecules that covalently inactivate cyclooxygenase-2. | 1998 | Science | pmid:9596581 |
Heller DA et al. | Mortality and biomarkers of aging in heterogeneous stock (HS) mice. | 1998 | J. Gerontol. A Biol. Sci. Med. Sci. | pmid:9597046 |